Novo Nordisk, A Top 1% Stock, Dives As Sales Of Obesity Blockbuster Drug MissInvestors Business Daily • 05/04/23
Wegovy weight-loss drug supply to be temporarily curtailed by Novo Nordisk as it ramps up productionMarket Watch • 05/04/23
Novo Nordisk Stock Skids As Obesity Drug Wegovy Misses ExpectationsInvestors Business Daily • 05/04/23
Novo Nordisk's sales increased by 27% in Danish kroner and by 25% at constant exchange rates to DKK 53.4 billion in the first three months of 2023GlobeNewsWire • 05/04/23
Novo Nordisk Sinks As Eli Lilly Plots Its Showdown In The Red-Hot Obesity Shot RaceInvestors Business Daily • 04/24/23
Senate legislation would cap insulin at $35 per month for people with private insuranceCNBC • 04/21/23